APA (7th ed.) Citation

Chalos, V., A. van de Graaf, R., Roozenbeek, B., C. G. M. van Es, A., M. den Hertog, H., Staals, J., . . . van der Steen, W. (2020). Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design. Trials, 21(1), 1. https://doi.org/10.1186/s13063-020-04514-9

Chicago Style (17th ed.) Citation

Chalos, Vicky, et al. "Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke. The Effect of Periprocedural Medication: Acetylsalicylic Acid, Unfractionated Heparin, Both, or Neither (MR CLEAN-MED). Rationale and Study Design." Trials 21, no. 1 (2020): 1. https://doi.org/10.1186/s13063-020-04514-9.

MLA (9th ed.) Citation

Chalos, Vicky, et al. "Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke. The Effect of Periprocedural Medication: Acetylsalicylic Acid, Unfractionated Heparin, Both, or Neither (MR CLEAN-MED). Rationale and Study Design." Trials, vol. 21, no. 1, 2020, p. 1, https://doi.org/10.1186/s13063-020-04514-9.